BRK-B vs CIF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CIF exhibits a stable financial health profile with a Piotroski F-Score of 6/9, though it is caught between a defensive Graham Number of $2.41 and a lower growth-based intrinsic value of $0.98. While the fund trades at a discount to book value (P/B 0.88), it faces significant fundamental headwinds including negative earnings growth (-10.20%) and a highly unsustainable dividend payout ratio of 124.67%. The technical trend is currently bearish (0/100), suggesting that the attractive yield is likely a 'dividend trap' given the lack of earnings coverage.
Compare Another Pair
Related Comparisons
BRK-B vs CIF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and MFS Intermediate High Income Fund (CIF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.